The Gravitate Health Project, an EU-funded initiative, focuses on empowering patients by providing them with clear, personalized digital health information to make their treatment safer and more effective. Established in November 2020 under the Innovative Medicines Initiative (IMI), the project brings together a wide range of partners from academia, industry, and health organizations across Europe. Its primary mission is to offer patients tools that improve their understanding of medication and health data, enabling them to become active participants in their healthcare decisions.
Gravitate Health stems from the recognition that many patients struggle to access and comprehend essential medical information. The project’s vision is to bridge this gap by leveraging digital platforms and tools to enhance patient engagement and safety. By working with universities, pharmaceutical companies, and regulatory bodies, the project seeks to create a robust ecosystem where patients are empowered with reliable, easy-to-understand health information.
The core mission of Gravitate Health is to provide patients with personalized, trusted digital health data. This includes information about medications, electronic product information (ePI), and health education materials. By utilizing open-source technology and a patient-centric approach, Gravitate Health aims to reduce medication risks and enhance the quality of life for users. The project encourages a two-way communication process between patients and healthcare providers, ensuring that patient needs are at the forefront of health data innovations.
Gravitate Health is built around a key innovation known as the G-lens, a digital tool designed to improve the access and understanding of electronic health records (EHRs), real-world data (RWD), and electronic product information (ePI) for medicines. This open-source platform allows healthcare professionals and patients to navigate trusted health information sources, ensuring data security and patient privacy. The platform integrates health data from multiple sources, making it easier for patients to understand and follow their treatment plans.
The project aims to:
Gravitate Health’s editorial process involves experts across various fields, including healthcare professionals, digital health innovators, and patient advocacy groups. The steering committee, project management team, and international advisory board oversee the project’s direction, ensuring that it aligns with the needs of its stakeholders. The collaboration includes major institutions such as the University of Oslo, Pfizer Ltd, and Karolinska Institutet, as well as various patient associations and regulatory bodies across Europe.
The project is governed by a General Assembly that includes representatives from each partner organization. This assembly ensures that decisions are made democratically and that the project’s goals are met effectively. The Project Coordination Team, led by experts such as Prof. Anne Moen from the University of Oslo and Dr. Giovanna Ferrari from Pfizer, handles the day-to-day operations, ensuring that the project runs smoothly.
Gravitate Health represents a groundbreaking step toward empowering patients with the health information they need to manage their medical treatments confidently. Through its innovative G-lens tool, the project aims to create a sustainable, patient-centered approach to digital health information, reducing the risks associated with improper medication use and improving overall health outcomes. The project’s collaborative structure, involving key players from academia, industry, and regulatory bodies, ensures a wide-reaching and long-lasting impact on the way patients interact with their healthcare data.